BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26390883)

  • 1. Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion.
    Zhao L; Wang Y; Xue Y; Lv W; Zhang Y; He S
    Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):890-8. PubMed ID: 26390883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
    Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma.
    Shen Z; Li T; Chen D; Jia S; Yang X; Liang L; Chai J; Cheng X; Yang X; Sun M
    Oncol Rep; 2014 Feb; 31(2):800-6. PubMed ID: 24337063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival.
    Chen L; Liu X; Zhang HY; Du W; Qin Z; Yao Y; Mao Y; Zhou L
    Oncotarget; 2014 Aug; 5(16):6576-83. PubMed ID: 25149529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia and macrophages promote glioblastoma invasion by the CCL4-CCR5 axis.
    Wang Y; Liu T; Yang N; Xu S; Li X; Wang D
    Oncol Rep; 2016 Dec; 36(6):3522-3528. PubMed ID: 27748906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion.
    Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F
    Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.
    Li W; Wu C; Yao Y; Dong B; Wei Z; Lv X; Zhang J; Xu Y
    Neurosci Lett; 2014 Apr; 566():82-7. PubMed ID: 24582898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme.
    Kranjc MK; Novak M; Pestell RG; Lah TT
    Radiol Oncol; 2019 Nov; 53(4):397-406. PubMed ID: 31747383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
    Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
    Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines.
    Jung TY; Jung S; Ryu HH; Jeong YI; Jin YH; Jin SG; Kim IY; Kang SS; Kim HS
    J Neurosurg; 2008 Aug; 109(2):273-84. PubMed ID: 18671640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
    Dhruv HD; Roos A; Tomboc PJ; Tuncali S; Chavez A; Mathews I; Berens ME; Loftus JC; Tran NL
    J Neurooncol; 2016 Feb; 126(3):397-404. PubMed ID: 26559543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.
    Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y
    Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling.
    Qiang Z; Jun-Jie L; Hai W; Hong L; Bing-Xi L; Lei C; Wei X; Ya-Wei L; Huang A; Song-Tao Q; Yun-Tao L
    Carcinogenesis; 2018 Feb; 39(2):214-224. PubMed ID: 29106517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.
    Pham K; Luo D; Liu C; Harrison JK
    J Neuroimmunol; 2012 May; 246(1-2):10-7. PubMed ID: 22425022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
    Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
    Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.